425 related articles for article (PubMed ID: 7821130)
1. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins.
Christie MR; Tun RY; Lo SS; Cassidy D; Brown TJ; Hollands J; Shattock M; Bottazzo GF; Leslie RD
Diabetes; 1992 Jul; 41(7):782-7. PubMed ID: 1612192
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
[TBL] [Abstract][Full Text] [Related]
10. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
12. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.
Kawasaki E; Moriuchi R; Takino H; Okuno S; Takao Y; Maeda Y; Yokota A; Yamamoto H; Chikuba N; Akazawa S
Diabetologia; 1992 Aug; 35(8):748-52. PubMed ID: 1511801
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
17. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
18. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
19. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.
Atkinson MA; Kaufman DL; Newman D; Tobin AJ; Maclaren NK
J Clin Invest; 1993 Jan; 91(1):350-6. PubMed ID: 8423231
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
